NCT04962737

Brief Summary

Somatosensory evoked potentials are crucial in determining the physiological changes of potentials in nerve pathways. Although their main function is diagnostic, the investigators have recently been used as a physiological test to determine physioelectric changes in healthy subjects to study applied stimuli, such as laser, pain or electrotherapy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
6mo left

Started Nov 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Nov 2025Oct 2026

First Submitted

Initial submission to the registry

July 9, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
4.4 years until next milestone

Study Start

First participant enrolled

November 28, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2026

Expected
Last Updated

August 22, 2025

Status Verified

August 1, 2025

Enrollment Period

5 months

First QC Date

July 9, 2021

Last Update Submit

August 21, 2025

Conditions

Keywords

physical therapy modalityElectric Stimulation TherapyEvoked PotentialsHealthy Volunteers

Outcome Measures

Primary Outcomes (1)

  • Response speed of the central and peripheral nervous system to a stimulus 1

    The Somatosensory Evoked Potentials of both median and ulnar nerves will be evaluated. Neurophysiological tests of the nervous system that functionally assesses the nerve pathways of the central and peripheral nervous system. For its evaluation, distal stimuli are generated in the wrists in the range of 3-4Hz with intensities above the sensitive threshold and below the pain threshold.

    Up to 1 month

Secondary Outcomes (3)

  • Response speed of the central and peripheral nervous system to a stimulus 2

    Up to 1 month

  • Response speed of the central and peripheral nervous system to a stimulus 3

    Up to 1 month

  • Response speed to sensitive stimuli in the palms of the hand and sole of the feet

    Up to 1 month

Study Arms (1)

Non-invasive Neuromodulation

EXPERIMENTAL

Non-invasive Neuromodulation Intervention with microcurrents: application of 6 electrodes per extremity and an adhesive electrode at C7 level.

Device: Non-invasive Neuromodulation

Interventions

The electrodes will be placed with the help of gloves and adapted socks for 1 hour, twice a week, until 10 intervention sessions are completed. In addition, depending on the session, an adhesive electrode will be placed at the level of C7. Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.3 s and pause of 300 ms, voltage 3 mV and intensity 0.5 μA.

Non-invasive Neuromodulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy people
  • Optimal cognitive abilities and mentally competent to participate in the study.
  • In condition to complete the study questionnaires.

You may not qualify if:

  • Focal mononeuropathies in both upper and lower limbs
  • Peripheral neuropathy.
  • Patients with implanted functioning pacemakers / defibrillators. Patients with bleeding disorders. Patients being treated with anticoagulants. Patients on antiplatelet therapy.
  • Present some of the contraindications for a treatment with NESA XSIGNAL®: pacemakers, internal bleeding, do not apply electrodes on skin in bad condition, with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and / or electricity phobia.
  • Not having signed the informed consent.
  • Present any injury or pathology during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Cheshire WP, Freeman R, Gibbons CH, Cortelli P, Wenning GK, Hilz MJ, Spies JM, Lipp A, Sandroni P, Wada N, Mano A, Ah Kim H, Kimpinski K, Iodice V, Idiaquez J, Thaisetthawatkul P, Coon EA, Low PA, Singer W. Electrodiagnostic assessment of the autonomic nervous system: A consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021 Feb;132(2):666-682. doi: 10.1016/j.clinph.2020.11.024. Epub 2020 Dec 22.

  • Cruccu G, Aminoff MJ, Curio G, Guerit JM, Kakigi R, Mauguiere F, Rossini PM, Treede RD, Garcia-Larrea L. Recommendations for the clinical use of somatosensory-evoked potentials. Clin Neurophysiol. 2008 Aug;119(8):1705-1719. doi: 10.1016/j.clinph.2008.03.016. Epub 2008 May 16.

  • Fallgatter AJ, Neuhauser B, Herrmann MJ, Ehlis AC, Wagener A, Scheuerpflug P, Reiners K, Riederer P. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm (Vienna). 2003 Dec;110(12):1437-43. doi: 10.1007/s00702-003-0087-6. Epub 2003 Jan 1.

  • Usami K, Kawai K, Sonoo M, Saito N. Scalp-recorded evoked potentials as a marker for afferent nerve impulse in clinical vagus nerve stimulation. Brain Stimul. 2013 Jul;6(4):615-23. doi: 10.1016/j.brs.2012.09.007. Epub 2012 Oct 11.

Study Officials

  • Aníbal Báez-Suárez, PhD

    University of Las Palmas de Gran Canaria

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aníbal Báez-Suárez, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 9, 2021

First Posted

July 15, 2021

Study Start

November 28, 2025

Primary Completion

April 15, 2026

Study Completion (Estimated)

October 20, 2026

Last Updated

August 22, 2025

Record last verified: 2025-08